SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-17-057472
Filing Date
2017-11-09
Accepted
2017-11-09 09:02:35
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 tv478890_s3.htm S-3 415660
2 EXHIBIT 1.2 tv478890_ex1-2.htm EX-1.2 240729
3 EXHIBIT 4.10 tv478890_ex4-10.htm EX-4.1 463061
4 EXHIBIT 5.1 tv478890_ex5-1.htm EX-5.1 36456
5 EXHIBIT 12.1 tv478890_ex12-1.htm EX-12.1 17514
6 EXHIBIT 23.1 tv478890_ex23-1.htm EX-23.1 2548
7 EXHIBIT 23.2 tv478890_ex23-2.htm EX-23.2 2293
8 EXHIBIT 23.3 tv478890_ex23-3.htm EX-23.3 5491
9 GRAPHIC tv478890_ex5-1img01.jpg GRAPHIC 7743
10 GRAPHIC tv478890_ex5-1img03.jpg GRAPHIC 6804
11 GRAPHIC tv478890_ex5-1img02.jpg GRAPHIC 5636
12 GRAPHIC tv478890_img01.jpg GRAPHIC 11993
13 GRAPHIC tv478890_img02.jpg GRAPHIC 8151
  Complete submission text file 0001144204-17-057472.txt   1241111
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-221443 | Film No.: 171188478
SIC: 8731 Services-Commercial Physical & Biological Research